National Academy of Sciences
Proceedings of the National Academy of Sciences, Volume 122, Issue 36, September 2025.
SignificanceAnthracyclines including doxorubicin are used by over 1 million cancer patients annually. Various tumors respond to these drugs, while others, such as pancreatic cancer, do not. We used the intrinsic fluorescence properties of these drugs to …
Read More
Manipulating anthracyclines for deeper tissue penetration and implications for glycolytic tissues
20:20
Proceedings of the National Academy of Sciences, Volume 122, Issue 36, September 2025. SignificanceAnthracyclines including doxorubicin are used by over 1 million cancer patients annually. Various tumors respond to these drugs, while others, such as pancreatic cancer, do not. We used the intrinsic fluorescence properties of these drugs to …
